MEDIFAST INC

MED Consumer Cyclical Personal Services

MEDIFAST INC’s revenue for fiscal 2025 (year ended December 2025) was $385.8 million, down 36.0% from fiscal 2024. In the quarter to June 2026, revenue fell 27.6%, EPS fell 221.7% and free cash flow grew 115.3%, each against the same quarter a year earlier. Dividend growth for five consecutive years; insiders bought in the last twelve months.

11.88 0.18 −1.49%
Market cap
$134.8M
P/E
0.0×
Fwd P/E
−7.4×
Dividend yield
—
F-score
4/9
Altman Z
4.46
Beneish M
n/a
Dividend safety
57/100

MEDIFAST INC (MED) EV/Sales

Alert me on EV/Sales

As of 16 October 2026, MEDIFAST INC (MED) trades at a EV/Sales of 0.0×. Over the past ten years it has ranged from −0.1× (July 2026) to 8.0× (September 2018); the current reading is higher than 6% of that period. That is below the Personal Services industry median of 1.3× and below the Consumer Cyclical sector median of 1.0×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 0.0× —
FY2024 0.1× (81.40%)
FY2023 0.6× (21.45%)
FY2022 0.8× (49.82%)
FY2021 1.6× (32.28%)
FY2020 2.3× 35.42%
FY2019 1.7× (38.98%)
FY2018 2.8× 9.44%
FY2017 2.5× 65.69%
FY2016 1.5× 41.05%

Quarterly newest first

Period EV/Sales Change
Jun 2026 0.0× —
Mar 2026 −0.1× —
Dec 2025 0.0× —
Sep 2025 0.0× (43.65%)
42 more quarters

Against its own ten years

Low −0.1× High 8.0×
Ten-year median 1.2×
Current reading's percentile 0

EV/Sales against peers

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on MED